Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy

Heart and Vessels

Volumn 29, Issue 1, 2014, Pages 88-96

  Ishii, Shunsuke ^a   Inomata, Takayuki ^a   Ikeda, Yuki ^a   Nabeta, Takeru ^a   Iwamoto, Miwa ^a   Watanabe, Ichiro ^a   Naruke, Takashi ^a   Shinagawa, Hisahito ^a   Koitabashi, Toshimi ^a   Nishii, Mototsugu ^a   Takeuchi, Ichiro ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; SPIRONOLACTONE;

ACUTE HEART FAILURE; ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG DOSE TITRATION; EVENT FREE SURVIVAL; FEMALE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART RATE; HEART VENTRICLE SIZE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LEFT VENTRICULAR EJECTION REVERSE REMODELING; LEFT VENTRICULAR END DIASTOLIC DIMENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; SURVIVAL PREDICTION; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA INDUCED CARDIOMYOPATHY; TREATMENT RESPONSE;

ADULT; AGED; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR AGENTS; DISEASE-FREE SURVIVAL; FEMALE; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATIENT ADMISSION; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84899110629     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-013-0335-0     Document Type: Article

References (33)

1. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA (1987) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113:1489-1494 (Pubitemid 17092823)
2. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR (1992) Altered myocardial force-frequency relation in human heart failure. Circulation 85:1743-1750
3. 31P magnetic resonance spectroscopy. Lancet 338:973-976
4. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C (2004) Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109:1674-1679 (Pubitemid 38451726)
5. Colin P, Ghaleh B, Monnet X, Hittinger L, Berdeaux A (2004) Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J Pharmacol Exp Ther 308:236-240 (Pubitemid 38090723)
6. Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost- Brama A, Lerebours G, Tavazzi L (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376:886-894
7. Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB (2008) Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF). J Am Coll Cardiol 52:347-356 (Pubitemid 352005813)
8. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1349-1539
9. Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S (2004) Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 147:324-330 (Pubitemid 38176834)
10. McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441-1446
11. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr, American College of Cardiology/American Heart Association (2001) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 38:2101-2113 (Pubitemid 33116591)
12. Düngen HD, Apostolović S, Inkrot S, Tahirović E, Krackhardt F, Pavlović M, Putniković B, Lainscak M, Gelbrich G, Edelmann F, Wachter R, Eschenhagen T, Waagstein F, Follath F, Rauchhaus M, Haverkamp W, Osterziel KJ, Dietz R (2008) Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial. Clin Res Cardiol 97:578-586
13. Aoki T, Fukumoto Y, Sugimura K, Oikawa M, Satoh K, Nakano M, Nakayama M, Shimokawa H (2011) Prognostic impact of myocardial interstitial fibrosis in non-ischemic heart failure. Comparison between preserved and reduced ejection fraction heart failure. Circ J 75:2605-2613
14. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293:572-580 (Pubitemid 40171239)
15. Aronson D, Mittleman MA, Burger AJ (2004) Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 116:466-473 (Pubitemid 38388616)
16. Flannery G, Gehrig-Mills R, Billah B, Krum H (2008) Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers. Am J Cardiol 101:865-869
17. Kim BH, Cho KI, Kim SM, Kim N, Han J, Kim JY, Kim IJ (2012) Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat. Heart Vessels. doi: 10.1007/s00380-012-0304-z
18. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293-302
19. Matsumori A (2003) Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure. Eur J Heart Fail 5:669-677
20. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709-717 (Pubitemid 29407370)
21. Camm AJ, Fei L (1996) Chronotropic incompetence, Part II: clinical implications. Clin Cardiol 19:503-508 (Pubitemid 26314293)
22. Lauer MS, Okin PM, Larson MG, Evans JC, Levy D (1996) Impaired heart rate response to graded exercise: prognostic implications of chronotropic incompetence in the Framingham Heart study. Circulation 93:1520-1526
23. Ellestad MH (1996) Chronotropic incompetence: the implication of heart rate response to exercise (compensatory parasympathetic hyperactivity?). Circulation 93:1485-1487
24. Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marwick TH (1999) Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA 281:524-529 (Pubitemid 29081305)
25. Chen JY, Lee YL, Tsai WC, Lee CH, Chen PS, Li YH, Tsai LM, Chen JH, Lin LJ (2011) Cardiac autonomic functions derived from short-term heart rate variability recordings associated with heart rate recovery after treadmill exercise test in young individuals. Heart Vessels 26:282-288
26. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR (1986) Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74:1290-1302 (Pubitemid 17189248)
27. Spyrou N, Rosen SD, Fath-Ordoubadi F, Jagathesan R, Foale R, Kooner JS, Camici PG (2002) Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. J Am Coll Cardiol 40:1216-1224
28. Umana E, Solares CA, Alpert MA (2003) Tachycardia-induced cardiomyopathy. Am J Med 114:51-55 (Pubitemid 36126516)
29. Gelb BD, Garson A Jr (1990) Noninvasive discrimination of right atrial ectopic tachycardia from sinus tachycardia in "dilated cardiomyopathy" . Am Heart J 120:886-891 (Pubitemid 20346155)
30. Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL (2011) Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 107:1065-1070
31. Francis GS, Tang WH (2003) Beta-blockers and reverse remodeling: what are the implications? Am Heart J 145:200-202 (Pubitemid 36207935)
32. Yamada T, Fukunami M, Ohmori M, Iwakura K, Kumagai K, Kondoh N, Minamino T, Tsujimura E, Nagareda T, Kotoh K, Hoki N (1993) Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint. J Am Coll Cardiol 21:628-633 (Pubitemid 23076279)
33. Kawai K, Takaoka H, Hata K, Yokoya Y, Yokoyama M (1999) Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy. Am J Cardiol 84:671-676 (Pubitemid 29417959)